Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2002-07-01 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: DUNKERQUE (59140), Nord
SELARL PHARMACIE SAINT POL JARDIN : revenue, balance sheet and financial ratios
SELARL PHARMACIE SAINT POL JARDIN is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in DUNKERQUE (59140),
this company of category PME
shows in 2024 a revenue of 3.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE SAINT POL JARDIN (SIREN 443105317)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
3 700 784 €
N/C
N/C
N/C
N/C
N/C
N/C
N/C
3 199 385 €
Net income
133 356 €
132 907 €
116 909 €
84 938 €
76 067 €
66 479 €
51 722 €
51 988 €
183 791 €
EBITDA
177 468 €
N/C
N/C
N/C
N/C
N/C
N/C
N/C
300 259 €
Net margin
3.6%
N/C
N/C
N/C
N/C
N/C
N/C
N/C
5.7%
Revenue and income statement
In 2024, SELARL PHARMACIE SAINT POL JARDIN achieves revenue of 3.7 M€. Revenue is growing positively over 9 years (CAGR: +1.8%). After deducting consumption (2.7 M€), gross margin stands at 1.0 M€, i.e. a rate of 28%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 177 k€, representing 4.8% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 133 k€, i.e. 3.6% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2024)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
3 700 784 €
Gross margin (2024)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
1 020 744 €
EBITDA (2024)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
177 468 €
EBIT (2024)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
169 864 €
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
133 356 €
EBITDA margin (2024)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
4.8%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 74%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.3 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 3.8% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
2.439%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
74.369%
Cash flow / Revenue (2024)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
3.793%
Repayment capacity (2024)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.304
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE SAINT POL JARDIN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
4.25
1.941
0.0
0.001
0.098
1.42
3.102
3.382
2.439
Financial autonomy
78.068
80.395
81.328
78.168
79.653
78.902
78.996
77.25
74.369
Repayment capacity
0.351
None
None
None
None
None
None
None
0.304
Cash flow / Revenue
6.55%
None%
None%
None%
None%
None%
None%
None%
3.793%
Sector positioning
Debt ratio
2.442024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of SELARL PHARMACIE SAINT PO... (2.44) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
74.37%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent
In 2024, the financial autonomy of SELARL PHARMACIE SAINT PO... (74.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.3 years2024
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Excellent
In 2024, the repayment capacity of SELARL PHARMACIE SAINT PO... (0.30) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 134.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.9x. Danger: operating income does not cover interest charges, unsustainable situation.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
134.534
Interest coverage (2024)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
0.875
Liquidity indicators evolution SELARL PHARMACIE SAINT POL JARDIN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
137.138
136.635
134.29
136.086
143.009
157.775
0.0
158.624
134.534
Interest coverage
2.621
None
None
None
None
None
None
None
0.875
Sector positioning
Liquidity ratio
134.532024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average+25 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE SAINT PO... (134.53) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
0.88x2024
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Average
In 2024, the interest coverage of SELARL PHARMACIE SAINT PO... (0.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 10 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 59 days. Excellent situation: suppliers finance 49 days of the operating cycle (retail model). Inventory turnover is 15 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 20 days of revenue, i.e. 202 k€ to permanently finance.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
202 137 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
10 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
59 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
15 j
WCR in days of revenue (2024)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
20 j
WCR and payment terms evolution SELARL PHARMACIE SAINT POL JARDIN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
214 103 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
202 137 €
Inventory turnover (days)
20
0
0
0
0
0
0
0
15
Customer payment term (days)
6
0
0
0
0
0
0
0
10
Supplier payment term (days)
49
0
0
0
0
0
0
0
59
Positioning of SELARL PHARMACIE SAINT POL JARDIN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE SAINT POL JARDIN is estimated at
1 901 960 €
(range 1 391 361€ - 2 725 952€).
With an EBITDA of 177 468€, the sector multiple of 9.2x is applied.
The price/revenue ratio is 0.64x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1391k€1901k€2725k€
1 901 960 €Range: 1 391 361€ - 2 725 952€
NAF 5 année 2024
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
177 468 €×9.2x
Estimation1 638 822 €
1 073 501€ - 2 548 030€
Revenue Multiple30%
3 700 784 €×0.64x
Estimation2 367 332 €
1 984 375€ - 2 982 937€
Net Income Multiple20%
133 356 €×14.0x
Estimation1 861 748 €
1 296 492€ - 2 785 282€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE SAINT POL JARDIN with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE SAINT POL JARDIN
What is the revenue of SELARL PHARMACIE SAINT POL JARDIN ?
The revenue of SELARL PHARMACIE SAINT POL JARDIN in 2024 is 3.7 M€.
Is SELARL PHARMACIE SAINT POL JARDIN profitable?
Yes, SELARL PHARMACIE SAINT POL JARDIN generated a net profit of 133 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE SAINT POL JARDIN ?
The headquarters of SELARL PHARMACIE SAINT POL JARDIN is located in DUNKERQUE (59140), in the department Nord.
Where to find the tax return of SELARL PHARMACIE SAINT POL JARDIN ?
The tax return of SELARL PHARMACIE SAINT POL JARDIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE SAINT POL JARDIN operate?
SELARL PHARMACIE SAINT POL JARDIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart